H. Narjes
Impact in
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
-
- Platelet Disorders and Treatments
Papers in
-
- Inflammatory mediators and NSAID effects 7
- Pharmacogenetics and Drug Metabolism 3
- Pharmacological Effects of Natural Compounds 1
- Oncology 6
- Drug Transport and Resistance Mechanisms 4
- Cancer Treatment and Pharmacology 2
- Co-authors
- G. Heinzel (9 shared papers)Ulrich Busch (7 shared papers)Gerhard Nehmiz (7 shared papers)Dominique Turck (6 shared papers)Dietmar Ganßer (2 shared papers)Peter Stopfer (2 shared papers)Thomas Ebner (1 shared paper)Mehdi Shahidi (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (4 papers)European Journal of Clinical Pharmacology (4 papers)The Journal of Clinical Pharmacology (2 papers)Circulation (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- GermanySwitzerlandSouth Korea
In The Last Decade
H. Narjes
17 papers receiving 440 citations
Peers
Comparison fields: 5 of 74
- Pharmacology 143
- Pharmacology 73
- Hematology 50
- Pharmaceutical Science 24
- Internal Medicine 10
Countries citing papers authored by H. Narjes
This map shows the geographic impact of H. Narjes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Narjes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Narjes more than expected).
Fields of papers citing papers by H. Narjes
This network shows the impact of papers produced by H. Narjes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Narjes. The network helps show where H. Narjes may publish in the future.
Co-authors
The 23 scholars most cited alongside H. Narjes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 114 | |
| 2 | 1997 | 67 | |
| 3 | Clinical pharmacokinetics of meloxicam. | 1997 | 64 |
| 4 | 1995 | 34 | |
| 5 | 1996 | 33 | |
| 6 | 1995 | 28 | |
| 7 | 1996 | 27 | |
| 8 | 2000 | 17 | |
| 9 | 1991 | 15 | |
| 10 | 1996 | 14 | |
| 11 | 2000 | 11 | |
| 12 | 1995 | 10 | |
| 13 | 2004 | 9 | |
| 14 | 1981 | 9 | |
| 15 | 1996 | 6 | |
| 16 | 1997 | 3 | |
| 17 | 2008 | 2 |
About H. Narjes
H. Narjes is a scholar working on Pharmacology, Oncology, Pharmacology, Cardiology and Cardiovascular Medicine and Genetics, having authored 17 papers that have together received 463 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (7 papers), Drug Transport and Resistance Mechanisms (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Estrogen and related hormone effects (2 papers), Cancer Treatment and Pharmacology (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Pharmacological Effects of Natural Compounds (1 paper) and Venous Thromboembolism Diagnosis and Management (1 paper). The work is most often cited by research in Pharmacology (143 citations), Pharmacology (73 citations), Hematology (50 citations), Pharmaceutical Science (24 citations) and Internal Medicine (10 citations). H. Narjes has collaborated with scholars based in Germany, Switzerland and South Korea. Frequent co-authors include G. Heinzel, Ulrich Busch, Gerhard Nehmiz, Dominique Turck, Dietmar Ganßer, Peter Stopfer, Thomas Ebner, Mehdi Shahidi, Kristell Marzin and Thomas Müller. Their work appears in journals such as British Journal of Clinical Pharmacology, European Journal of Clinical Pharmacology, The Journal of Clinical Pharmacology, Circulation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.